Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Potential new treatment for Alzheimer's disease disclosed by SIBIA Neurosciences

Sep. 6, 1996

Reversible MAO inhibitors from Hoechst Marion Roussel

Sep. 6, 1996

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

alpha1-Adrenoceptor antagonist effective in suppressing prostate cancer growth

Sep. 6, 1996

Abbott evaluating clitocine analogues

Sep. 6, 1996

Abbott describes immunosuppressants

Sep. 6, 1996

HIV protease inhibitor under evaluation at Pharmacia & Upjohn

Sep. 6, 1996

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

NSC-665158: HIV-1 reverse transcriptase inhibitor analogue

Aug. 30, 1996

Merck & Co. reports on L-163689

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...